» Articles » PMID: 23941879

Skeletal Muscle Denervation Causes Skeletal Muscle Atrophy Through a Pathway That Involves Both Gadd45a and HDAC4

Overview
Date 2013 Aug 15
PMID 23941879
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal muscle denervation causes muscle atrophy via complex molecular mechanisms that are not well understood. To better understand these mechanisms, we investigated how muscle denervation increases growth arrest and DNA damage-inducible 45α (Gadd45a) mRNA in skeletal muscle. Previous studies established that muscle denervation strongly induces Gadd45a mRNA, which increases Gadd45a, a small myonuclear protein that is required for denervation-induced muscle fiber atrophy. However, the mechanism by which denervation increases Gadd45a mRNA remained unknown. Here, we demonstrate that histone deacetylase 4 (HDAC4) mediates induction of Gadd45a mRNA in denervated muscle. Using mouse models, we show that HDAC4 is required for induction of Gadd45a mRNA during muscle denervation. Conversely, forced expression of HDAC4 is sufficient to increase skeletal muscle Gadd45a mRNA in the absence of muscle denervation. Moreover, Gadd45a mediates several downstream effects of HDAC4, including induction of myogenin mRNA, induction of mRNAs encoding the embryonic nicotinic acetylcholine receptor, and, most importantly, skeletal muscle fiber atrophy. Because Gadd45a induction is also a key event in fasting-induced muscle atrophy, we tested whether HDAC4 might also contribute to Gadd45a induction during fasting. Interestingly, however, HDAC4 is not required for fasting-induced Gadd45a expression or muscle atrophy. Furthermore, activating transcription factor 4 (ATF4), which contributes to fasting-induced Gadd45a expression, is not required for denervation-induced Gadd45a expression or muscle atrophy. Collectively, these results identify HDAC4 as an important regulator of Gadd45a in denervation-induced muscle atrophy and elucidate Gadd45a as a convergence point for distinct upstream regulators during muscle denervation and fasting.

Citing Articles

ALDH3A1-mediated detoxification of reactive aldehydes contributes to distinct muscle responses to denervation and Amyotrophic Lateral Sclerosis progression.

Li A, Dong L, Li X, Yi J, Ma J, Zhou J bioRxiv. 2024; .

PMID: 39677625 PMC: 11642873. DOI: 10.1101/2024.12.02.626422.


Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis.

Wischnewski S, Thawel T, Ikenaga C, Kocharyan A, Lerma-Martin C, Zulji A Nat Aging. 2024; 4(7):969-983.

PMID: 38834884 PMC: 11257986. DOI: 10.1038/s43587-024-00645-9.


Senolytic treatment does not mitigate oxidative stress-induced muscle atrophy but improves muscle force generation in CuZn superoxide dismutase knockout mice.

Borowik A, Lawrence M, Peelor 3rd F, Piekarz K, Crosswhite A, Richardson A Geroscience. 2024; 46(3):3219-3233.

PMID: 38233728 PMC: 11009189. DOI: 10.1007/s11357-024-01070-x.


The mitochondrial ATP-dependent potassium channel (mitoK) controls skeletal muscle structure and function.

di Marco G, Gherardi G, De Mario A, Piazza I, Baraldo M, Mattarei A Cell Death Dis. 2024; 15(1):58.

PMID: 38233399 PMC: 10794173. DOI: 10.1038/s41419-024-06426-x.


GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscle.

Marcotte G, Miller M, Kunz H, Ryan Z, Strub M, Vanderboom P JCI Insight. 2023; 8(22).

PMID: 37815864 PMC: 10721312. DOI: 10.1172/jci.insight.171772.


References
1.
Sumpio B . Foot ulcers. N Engl J Med. 2000; 343(11):787-93. DOI: 10.1056/NEJM200009143431107. View

2.
Gonzalez De Aguilar J, Niederhauser-Wiederkehr C, Halter B, de Tapia M, di Scala F, Demougin P . Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics. 2007; 32(2):207-18. DOI: 10.1152/physiolgenomics.00017.2007. View

3.
Cohen T, Waddell D, Barrientos T, Lu Z, Feng G, Cox G . The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem. 2007; 282(46):33752-33759. DOI: 10.1074/jbc.M706268200. View

4.
Schiffman P, Belsh J . Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest. 1993; 103(2):508-13. DOI: 10.1378/chest.103.2.508. View

5.
Haverkamp L, Appel V, Appel S . Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995; 118 ( Pt 3):707-19. DOI: 10.1093/brain/118.3.707. View